GSK posts blowout RSV vaccine sales, raises outlook
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Dado Ruvic | ReutersGlaxoSmithKline on ...
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Dado Ruvic | ReutersGlaxoSmithKline on ...
A vaccine from GlaxoSmithKline showed the potential to guard adults ages 50 to 59 from respiratory syncytial virus in a ...
Jun Li | Istock | Getty ImagesGlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK's ...
Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesThe Centers for Disease Control and Prevention on Thursday beneficial that adults ...
Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesVaccinating a million adults ages 65 and above with a single RSV ...
A medical examiner prepares a flu vaccine shot before administering it to an area resident in Los Angeles, the US, ...
Respiratory syncytial virus viral vaccine under research.Hailshadow | Istock | Getty ImagesGlaxoSmithKline on Wednesday said its vaccine to guard adults ...
A GSK lab in London.Oli Scarff | Getty ImagesThe Food and Drug Administration on Wednesday approved an RSV vaccine produced ...
A Johnson & Johnson constructing is shown in Irvine, California.Mike Blake | ReutersJohnson & Johnson on Wednesday said it's ducking ...
The Food and Drug Administration's independent panel of advisors on Wednesday beneficial GlaxoSmithKline's RSV vaccine for adults ages 60 and ...
[mailpoet_form id=”1″]
© 2022. All Right Reserved By Inbvnews.com